Skip to main content

07.05.2024 | Original Article

Acute liver failure histopathology: A 5-year retrospective study

verfasst von: Nalini Bansal, Mukul Rastogi, Komal Agrawal, Vivek Vij, Ajitabh Srivastava

Erschienen in: Indian Journal of Gastroenterology

Einloggen, um Zugang zu erhalten

Abstract

Background

Acute liver failure (ALF) is a rare, life-threatening disease of diverse etiology. It is defined as severe acute liver injury for fewer than 26 weeks' duration with encephalopathy and impaired synthetic function (international normalized ratio [INR] of 1.5 or higher) in a patient without cirrhosis or pre-existing liver disease. The diagnosis rests mainly on the clinical ground with wide range of pathological features. The present study seeks to explore the diverse histological patterns observed in cases for ALF and assess their usefulness in determining the underlying causes for the condition.

Methodology

A retrospective cross-sectional study was conducted among patients of ALF who underwent liver transplant and transjugular liver biopsy over a five-year period. From 1082 explant liver and 2446 liver biopsies, 22 cases of ALF (10 explants and 12 liver biopsies) were included in the study. Clinical and laboratory details were retrieved and histological findings were reviewed.

Result

Age ranged from 10 to 72 years (mean age, 40 years). There was a female predominance with a male:female ratio of 1:1.7. The commonest cause for ALF was virus-induced hepatocellular damage in 36.3% (eight patients), followed by autoimmune hepatitis in 22.7% (five patients), drug-induced liver injury (DILI) in 18.1% (four patients), cryptogenic in 13.6% (three patients) and ischemic injury secondary to large vein thrombosis in 9.0% (two) patients. The histological patterns identified were categorized into six categories. A more comprehensive morphological evaluation was conducted specifically for cases of ALF associated with autoimmune hepatitis (AIH) and compared with other cases of ALF.

Conclusion

In summary, our present study illustrates a morphological overlap in various patterns for the purpose of etiological assessment. In cases of AIH ALF, the presence of portal plasma cell infiltrate and central perivenulitis were identified as significant histological features to guide diagnosis.

Graphical Abstract

Literatur
1.
Zurück zum Zitat Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–98.PubMed Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–98.PubMed
2.
Zurück zum Zitat European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical practice guidelines panel, Wendon J, Panel members, Cordoba J, Dhawan A, Larsen FS, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017;66:1047–81. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical practice guidelines panel, Wendon J, Panel members, Cordoba J, Dhawan A, Larsen FS, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017;66:1047–81.
3.
Zurück zum Zitat O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273–5.CrossRefPubMed O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273–5.CrossRefPubMed
4.
Zurück zum Zitat Rovegno M, Vera M, Ruiz A, et al. Current concepts in acute liver failure. Ann Hepatol. 2019;18:543–52. Rovegno M, Vera M, Ruiz A, et al. Current concepts in acute liver failure. Ann  Hepatol. 2019;18:543–52.
5.
Zurück zum Zitat Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364–72.CrossRefPubMed Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364–72.CrossRefPubMed
7.
8.
Zurück zum Zitat Das P, Jain D, Das A. A retrospective autopsy study of histopathologic spectrum and etiologic trend of fulminant hepatic failure from north India. Diagn Pathol. 2007;2:27.CrossRefPubMedPubMedCentral Das P, Jain D, Das A. A retrospective autopsy study of histopathologic spectrum and etiologic trend of fulminant hepatic failure from north India. Diagn Pathol. 2007;2:27.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Quaglia A, Portmann BC, Knisely AS, et al. Auxiliary transplantation for acute liver failure: histopathological study of native liver regeneration. Liver Transpl. 2008;14:1437–48. Quaglia A, Portmann BC, Knisely AS, et al. Auxiliary transplantation for acute liver failure: histopathological study of native liver regeneration. Liver Transpl. 2008;14:1437–48.
10.
Zurück zum Zitat Kwong S, Meyerson C, Zheng W, et al. Acute hepatitis and acute liver failure: pathologic diagnosis and differential diagnosis. Semin Diagn Pathol. 2019;36:404–14. Kwong S, Meyerson C, Zheng W, et al. Acute hepatitis and acute liver failure: pathologic diagnosis and differential diagnosis. Semin Diagn Pathol. 2019;36:404–14.
11.
Zurück zum Zitat Hanau C, Munoz SJ, Rubin R. Histopathological heterogeneity in fulminant hepatic failure. Hepatology. 1995;21:345–51.PubMed Hanau C, Munoz SJ, Rubin R. Histopathological heterogeneity in fulminant hepatic failure. Hepatology. 1995;21:345–51.PubMed
12.
Zurück zum Zitat Stravitz RT, Lefkowitch JH, Fontana RJ, et al. Autoimmune liver failure: proposed clinical and histological criteria. Hepatology. 2011;53:517–26.CrossRefPubMed Stravitz RT, Lefkowitch JH, Fontana RJ, et al. Autoimmune liver failure: proposed clinical and histological criteria. Hepatology. 2011;53:517–26.CrossRefPubMed
Metadaten
Titel
Acute liver failure histopathology: A 5-year retrospective study
verfasst von
Nalini Bansal
Mukul Rastogi
Komal Agrawal
Vivek Vij
Ajitabh Srivastava
Publikationsdatum
07.05.2024
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-024-01588-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.